News

The large-scale study could help to target new ways of preventing and treating these diseases.

Collaboration aims to distribute RosettaGx Reveal thyroid cancer diagnostic in Israel.

Agreement designed to improve livelihoods of smallholder maize and wheat farmers globally.

Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.

T cell receptor (TCR) therapeutic candidates against four targets to be generated using Medigene’s proprietary TCR technology platform and bluebird bio’s lentiviral vector, genome editing, synthetic biology, and manufacturing capabilities.

Amgen to receive worldwide exclusive license to Arrowhead's RNAi ARC-LPA program.

Enhances Charles River’s early-stage capabilities in bioanalytical services.

EFSA is to release the raw data used in the recent EU safety evaluation of glyphosate, as part of its commitment to open risk assessment.

Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.

Partnership aims to provide an improved Viral Safety Service offering to biopharmaceutical companies.